Brennan Kevin M. bought XLO
January 1, 2024 · Form 4 insider transaction
Brennan Kevin M. bought 20,000 shares of Xilio Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderBrennan Kevin M.
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 1, 2024
Filing dateJanuary 3, 2024
Shares owned after20,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.; These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.